Astrocytoma risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 17: | Line 17: | ||
**# Polycyclic aromatic hydrocarbons. | **# Polycyclic aromatic hydrocarbons. | ||
** Past [[radiation therapy]] to the [[brain]]<ref name="pmid29717567">{{cite journal |vauthors=Sheppard JP, Nguyen T, Alkhalid Y, Beckett JS, Salamon N, Yang I |title=Risk of Brain Tumor Induction from Pediatric Head CT Procedures: A Systematic Literature Review |journal=Brain Tumor Res Treat |volume=6 |issue=1 |pages=1–7 |date=April 2018 |pmid=29717567 |pmc=5932294 |doi=10.14791/btrt.2018.6.e4 |url=}}</ref> | ** Past [[radiation therapy]] to the [[brain]]<ref name="pmid29717567">{{cite journal |vauthors=Sheppard JP, Nguyen T, Alkhalid Y, Beckett JS, Salamon N, Yang I |title=Risk of Brain Tumor Induction from Pediatric Head CT Procedures: A Systematic Literature Review |journal=Brain Tumor Res Treat |volume=6 |issue=1 |pages=1–7 |date=April 2018 |pmid=29717567 |pmc=5932294 |doi=10.14791/btrt.2018.6.e4 |url=}}</ref> | ||
* Genetic Disorders Risk factors:<ref name="pmid26892650">{{cite journal |vauthors=Soura E, Eliades PJ, Shannon K, Stratigos AJ, Tsao H |title=Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome |journal=J. Am. Acad. Dermatol. |volume=74 |issue=3 |pages=395–407; quiz 408–10 |date=March 2016 |pmid=26892650 |pmc=4761105 |doi=10.1016/j.jaad.2015.08.038 |url=}}</ref> | * Genetic Disorders Risk factors:<ref name="pmid26892650">{{cite journal |vauthors=Soura E, Eliades PJ, Shannon K, Stratigos AJ, Tsao H |title=Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome |journal=J. Am. Acad. Dermatol. |volume=74 |issue=3 |pages=395–407; quiz 408–10 |date=March 2016 |pmid=26892650 |pmc=4761105 |doi=10.1016/j.jaad.2015.08.038 |url=}}</ref><ref name="pmid24789122">{{cite journal |vauthors=Chourmouzi D, Papadopoulou E, Konstantinidis M, Syrris V, Kouskouras K, Haritanti A, Karkavelas G, Drevelegas A |title=Manifestations of pilocytic astrocytoma: a pictorial review |journal=Insights Imaging |volume=5 |issue=3 |pages=387–402 |date=June 2014 |pmid=24789122 |pmc=4035491 |doi=10.1007/s13244-014-0328-2 |url=}}</ref><ref name="pmid27656320">{{cite journal |vauthors=Gajavelli S, Nakhla J, Nasser R, Yassari R, Weidenheim KM, Graber J |title=Ollier disease with anaplastic astrocytoma: A review of the literature and a unique case |journal=Surg Neurol Int |volume=7 |issue=Suppl 23 |pages=S607–11 |date=2016 |pmid=27656320 |pmc=5025950 |doi=10.4103/2152-7806.189731 |url=}}</ref> | ||
** Neurofibromatosis | ** Neurofibromatosis | ||
** Tuberous sclerosis | ** Tuberous sclerosis | ||
Revision as of 16:00, 2 January 2019
|
Astrocytoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Study |
|
Astrocytoma risk factors On the Web |
|
American Roentgen Ray Society Images of Astrocytoma risk factors |
|
Risk calculators and risk factors for Astrocytoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Risk Factors
Common Risk Factors
- Envirmontal Risk Factors:
- Exposure to:[1]
- Vinyl chloride
- Phenols
- Organic solvents
- Pesticides
- Formaldehyde
- Lubricating fluids
- Polycyclic aromatic hydrocarbons.
- Past radiation therapy to the brain[2]
- Exposure to:[1]
- Genetic Disorders Risk factors:[3][4][5]
- Neurofibromatosis
- Tuberous sclerosis
- Li-Fraumeni syndrome
- Nevoid basal cell carcinoma syndrome
- Turcot syndrome
- Melanoma-astrocytoma syndrome
Less Common Risk Factors
References
- ↑ Caporalini C, Buccoliero AM, Scoccianti S, Moscardi S, Simoni A, Pansini L, Bordi L, Ammannati F, Taddei GL (2016). "Granular cell astrocytoma: report of a case and review of the literature". Clin. Neuropathol. 35 (4): 186–93. doi:10.5414/NP300952. PMID 27125869.
- ↑ Sheppard JP, Nguyen T, Alkhalid Y, Beckett JS, Salamon N, Yang I (April 2018). "Risk of Brain Tumor Induction from Pediatric Head CT Procedures: A Systematic Literature Review". Brain Tumor Res Treat. 6 (1): 1–7. doi:10.14791/btrt.2018.6.e4. PMC 5932294. PMID 29717567.
- ↑ Soura E, Eliades PJ, Shannon K, Stratigos AJ, Tsao H (March 2016). "Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome". J. Am. Acad. Dermatol. 74 (3): 395–407, quiz 408–10. doi:10.1016/j.jaad.2015.08.038. PMC 4761105. PMID 26892650.
- ↑ Chourmouzi D, Papadopoulou E, Konstantinidis M, Syrris V, Kouskouras K, Haritanti A, Karkavelas G, Drevelegas A (June 2014). "Manifestations of pilocytic astrocytoma: a pictorial review". Insights Imaging. 5 (3): 387–402. doi:10.1007/s13244-014-0328-2. PMC 4035491. PMID 24789122.
- ↑ Gajavelli S, Nakhla J, Nasser R, Yassari R, Weidenheim KM, Graber J (2016). "Ollier disease with anaplastic astrocytoma: A review of the literature and a unique case". Surg Neurol Int. 7 (Suppl 23): S607–11. doi:10.4103/2152-7806.189731. PMC 5025950. PMID 27656320.
- ↑ BUCKWALTER JA, TURNER JH, GAMBER HH, RATERMAN L, SOPER RT, KNOWLER LA (April 1959). "Psychoses, intracranial neoplasms, and genetics". AMA Arch Neurol Psychiatry. 81 (4): 480–5. PMID 13636517.
- ↑ 7.0 7.1 Schlehofer B, Blettner M, Becker N, Martinsohn C, Wahrendorf J (May 1992). "Medical risk factors and the development of brain tumors". Cancer. 69 (10): 2541–7. PMID 1568177.
- ↑ Hochberg F, Toniolo P, Cole P (November 1984). "Head trauma and seizures as risk factors of glioblastoma". Neurology. 34 (11): 1511–4. PMID 6493505.